Litcius/Paper detail

Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial

Celia A J Michielsens, Nathan den Broeder, F.H.J. van den Hoogen, E. Mahler, Steven Teerenstra, Désirée van der Heijde, Lise M Verhoef, Alfons A den Broeder

2022Annals of the Rheumatic Diseases34 citationsDOIOpen Access PDF

Topics & Concepts

TaperingMedicinePsoriatic arthritisClinical endpointPsoriasisRandomized controlled trialRheumatoid arthritisInternal medicineAxial spondyloarthritisSurgeryArthritisDermatologySacroiliitisComputer graphics (images)Computer scienceSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and Pathogenesis
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial | Litcius